ストックスクリーナーアプリを入手
84.86
1.78%
-1.54
アフターアワーズ：
84.56
-0.30
-0.35%
前日終値:
$86.40
開ける：
$86.67
24時間の取引高:
1.48M
Relative Volume:
0.74
時価総額：
$11.13B
収益：
$982.02M
当期純損益:
$-416.28M
株価収益率:
-25.60
EPS:
-3.3148
ネットキャッシュフロー:
$-233.07M
1週間 パフォーマンス:
-8.60%
1か月 パフォーマンス:
-0.74%
6か月 パフォーマンス:
+32.20%
1年 パフォーマンス:
+89.21%
1日の値動き範囲:
$84.32
$88.20
1週間の範囲:
$74.55
$92.40
52週間の値動き範囲:
$36.36
$120.74
Guardant Health Inc Stock (GH) Company Profile
Compare GH vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
84.86 | 11.33B | 982.02M | -416.28M | -233.07M | -3.3148 |
TMO
Thermo Fisher Scientific Inc
|
531.67 | 195.93B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
198.14 | 140.56B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
580.76 | 46.39B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
119.77 | 34.02B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
326.20 | 32.49B | 3.17B | 642.63M | 516.49M | 10.77 |
Guardant Health Inc Stock (GH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-20 | 繰り返されました | Canaccord Genuity | Buy |
| 2026-02-17 | 開始されました | Robert W. Baird | Outperform |
| 2026-01-05 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2025-12-02 | 再開されました | Morgan Stanley | Overweight |
| 2025-09-25 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-09-22 | 再開されました | Wells Fargo | Overweight |
| 2025-04-10 | 開始されました | Mizuho | Outperform |
| 2025-01-23 | 開始されました | Barclays | Overweight |
| 2024-06-28 | アップグレード | Guggenheim | Neutral → Buy |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-24 | 再開されました | Craig Hallum | Buy |
| 2023-12-14 | 開始されました | Guggenheim | Neutral |
| 2023-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2023-11-13 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-09-27 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-05-26 | アップグレード | Citigroup | Neutral → Buy |
| 2023-05-05 | 開始されました | UBS | Buy |
| 2023-03-09 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
| 2022-11-01 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | 開始されました | Craig Hallum | Buy |
| 2022-10-06 | 開始されました | Stephens | Overweight |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-06-03 | 開始されました | Piper Sandler | Overweight |
| 2022-04-28 | 再開されました | BTIG Research | Buy |
| 2022-02-24 | 繰り返されました | Canaccord Genuity | Buy |
| 2022-02-24 | 繰り返されました | Citigroup | Buy |
| 2022-02-24 | 繰り返されました | Cowen | Outperform |
| 2022-02-24 | 繰り返されました | Morgan Stanley | Overweight |
| 2022-02-24 | 繰り返されました | SVB Leerink | Outperform |
| 2022-02-24 | 繰り返されました | Stifel | Buy |
| 2022-02-24 | 繰り返されました | Wells Fargo | Overweight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-06-15 | 開始されました | Raymond James | Mkt Perform |
| 2021-06-03 | 開始されました | Goldman | Buy |
| 2021-05-25 | 開始されました | Wells Fargo | Overweight |
| 2021-01-11 | 開始されました | Stifel | Buy |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-06-12 | 開始されました | BTIG Research | Buy |
| 2020-02-21 | 開始されました | Guggenheim | Buy |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-08-07 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-04-16 | 開始されました | Canaccord Genuity | Buy |
| 2019-04-10 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | 繰り返されました | BofA/Merrill | Neutral |
| 2018-10-29 | 開始されました | BofA/Merrill | Neutral |
| 2018-10-29 | 開始されました | JP Morgan | Overweight |
| 2018-10-29 | 開始されました | William Blair | Outperform |
すべてを表示
Guardant Health Inc (GH) 最新ニュース
Barclays Maintains Guardant Health(GH.US) With Buy Rating, Cuts Target Price to $115 - Moomoo
Mizuho Securities Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $135 - Moomoo
TD Cowen cuts Guardant Health stock price target on valuation By Investing.com - Investing.com Canada
Cloudflare, ServiceNow, And Guardant Health Are Among Top 10 Large-Cap Losers Last Week (April 6-April 10 - Benzinga
Oscar, Guardant, Redwire, Gap, AFLAC: Insider Moves Shock Wall Street - TipRanks
Guardant Health Surges to $510 Million in Trading Volume as Insiders and Institutional Investors Dispute Over $81 Share Price - Bitget
(GH) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
GH Stock Price, Quote & Chart | GUARDANT HEALTH INC (NASDAQ:GH) - ChartMill
Guardant Health real-world data supports Japan approval of ENHERTU for HER2-positive tumors - MSN
Guardant Health (GH) partners with Manulife to launch Shield multi-cancer detection test in Asia - MSN
Guardant Health Inc (GH) Stock Price Down 4.62% on Apr 9 - GuruFocus
Why Guardant Health’s (GH) 2026 screening story reinforced Piper Sandler’s bullish view - MSN
US Market Recap: Is now the right time to enter Guardant Health IncEarnings Miss & Community Consensus Stock Picks - baoquankhu1.vn
Multi-Cancer Early Detection Testing Market to Reach USD 7.52 - openPR.com
Aberdeen Group Trims Stake in Guardant Health - National Today
Aug Summary: Can Guardant Health Inc keep up with sector leaders2026 Catalysts & High Conviction Buy Zone Picks - baoquankhu1.vn
OS Therapies Appoints Craig Eagle, MD as Strategic Advisor - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Guardant Health (GH) and Compass Therapeutics (CMPX) - The Globe and Mail
Insider Sell: Terilyn Monroe Sells Shares of Guardant Health Inc (GH) - GuruFocus
Guardant Health (GH) chief people officer sells $355k in stock - Investing.com India
Guardant Health Insider Sells $355K in Shares - National Today
Guardant Health (GH) chief people officer sells $355k in stock By Investing.com - Investing.com South Africa
Guardant Health (GH) Chief People Officer sells 3,832 shares in open market - Stock Titan
CCORF Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $135 - Moomoo
Guardant Health (GH) Positioned for Potential Upside, Says Citi - GuruFocus
Canaccord reiterates Guardant Health stock rating on cancer test growth - Investing.com
How does Guardant Health Inc compare to its peers2026 Biggest Moves & Risk Managed Investment Strategies - baoquankhu1.vn
Guardant Health, Inc. (GH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know - Yahoo Finance
Guardant Health: Leveraging Liquid Biopsy Testing Momentum (NASDAQ:GH) - Seeking Alpha
[144] Guardant Health, Inc. SEC Filing - Stock Titan
Guardant Health (GH) Sees Price Target Reduction from Evercore I - GuruFocus
Guardant Health, Inc. $GH is Capricorn Fund Managers Ltd's 6th Largest Position - MarketBeat
SG Americas Securities LLC Invests $1.74 Million in Guardant Health, Inc. $GH - MarketBeat
Guardant Health, Inc. (GH) stock price, news, quote and history - Yahoo Finance UK
Guardant Health, Inc. (NASDAQ:GH) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Guardant Health (GH) Valuation Check After Strong 1 Year Return And Recent 90 Day Pullback - Yahoo Finance
Guardant Health, Inc. (GH) Stock forecasts - Yahoo Finance UK
Guardant Health Inc (5GH.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada
guardant health stock — Guardant Health, Inc. (NASDAQ: GH) - Bitget
Guardant Health (NASDAQ: GH) CLO converts RSUs, withholds shares for taxes - Stock Titan
Guardant Health (GH) CPO gains stock from RSU vesting and tax withholding - Stock Titan
Guardant Health Inc (GH) 財務データ
収益
当期純利益
現金流量
EPS
1.41%
1.61%
大文字化:
|
ボリューム (24 時間):